Mon, Nov 04, 2024
Despite this setback, Sun Pharma’s stock has rallied 43 per cent year-to-date, fueled by growth in speciality drugs, emerging markets, and domestic sales.
More >
Mon, Oct 28, 2024
Led by growth in its domestic business, the specialty generic pharma company is expected to post good July-September quarter.
Wed, Sep 11, 2024
Share Market News: The Sensex ended 398.1 points lower at 81,523.2 while the Nifty50 settled at 24,918.5, down 122.7 points from its previous close.
Wed, Feb 08, 2023
Dividend Stocks Today, February 8: A total of thirteen stocks will trade ex-dividend on Wednesday, February 8, according to the NSE website.
Sat, Feb 04, 2023
Zee Business brings to you 3 stocks recommended by brokerage firms to keep an eye out for.
Wed, Feb 01, 2023
Budget 2023: Here's what brokerages make of stocks such as Sun Pharma, Godrej Consumer and Indian Oil on February 1 — the day Finance Minister Nirmala Sitharaman presents Budget 2023 in Parliament.
Tue, Jan 31, 2023
Sun Pharma Q3 Results: The pharmaceutical major reported a 5.2 per cent year-on-year increase in net profit to Rs 2,166 crore for the quarter ended December 2022.
Mon, Jan 30, 2023
All the brands are approved by the Drugs Controller General of India (DCGI) for post-operative inflammation in patients undergoing minor surgery and dental procedures, Sun Pharma said in a statement.
Mon, Jan 23, 2023
Despite strong momentum, the Nifty50 has failed to take out resistance at 18,180, trading above its 20-day simple moving average.
Stocks to buy: Brokerage firms have recommended five stocks having the potential to yield up to 39 per cent return to investors.
Thu, Jan 19, 2023
Outlining the wishlist for the sector in the upcoming Union Budget, IPA Secretary General Sudarshan Jain said the domestic pharma industry is currently around USD 50 billion in size and aspires to grow to around USD 130 billion by 2030 and USD 450 billion by 2047.
Brokerages are upbeat on IndusInd Bank, a day after the private lender reported a robust set of earnings for the October-December period. Macquarie is bullish on Sun Pharma mainly on the drug maker's rising market share of dry eye disease treatment CEQUA.
Mon, Jan 16, 2023
Stocks to buy: Brokerage firms have recommended five stocks having the potential to yield up to 30 per cent return to investors.
Sun, Jan 15, 2023
In a warning letter, the US Food and Drug Administration (USFDA) pointed out various lapses at the Halol plant which produces finished pharmaceutical products.
Wed, Jan 11, 2023
Extending losses to a second straight session, the Sensex lost 10 points to end at 60,105.5 and the Nifty50 settled at 17,895.7, down 18.5 points from its previous close.
Wed, Jan 04, 2023
Brokerage firm Sharekhan have recommended three stocks having the potential to yield up to 25%. One may consider the brokerage recommendations for positive yield.
Thu, Dec 22, 2022
The research team of Research Analyst Ashish Chaturvedi and Varun Dubey recommends a buy, sell or hold strategy in cash stocks, futures and gives their best picks for today.
Wed, Dec 21, 2022
The 30-share BSE benchmark Sensex tumbled 635.05 points or 1.03 per cent to settle at 61,067.24. While the broader NSE Nifty declined 186.20 points or 1.01 per cent to end at 18,199.10.
To review the Covid preparedness, Union Health Minister Mansukh Mandaviya chaired a meeting with top officials as fresh spurt in cases in countries like Japan, South Korea, Brazil, China, and the US.
Mon, Dec 19, 2022
In today's edition of Traders Diary, Zee Business research team brings its exclusive research on 20 stocks that investors and traders can refer to while making their strategies in them
Thu, Dec 15, 2022
Nifty, Sensex Top Gainers & Losers: The benchmark indices such as Sensex plummeted 879 points while the Nifty crashed below the 18,415 mark on Thursday, in tandem with a global sell-off after the US Federal Reserve increased the interest rate and signalled more hikes in its fight against infl
Fri, Dec 09, 2022
Sun Pharma share price: Stocks of Sun Pharmaceutical Industries Limited, NSE: SUNPHARMA traded flat in early morning deals on Friday.
Thu, Dec 08, 2022
Markets are seeing time-wise correction and weak global cues are delaying the recovery, Ajit Mishra, VP - Technical Research, Religare Broking.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
